News | October 10, 2025
Delhi High Court refuses to restrain Natco from manufacturing spinal muscular atrophy drug
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Investment to expand manufacturing and global medicine supply capacity
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Subscribe To Our Newsletter & Stay Updated
